Crinetics Pharmaceuticals, Inc.: Form 8-K filed 2026-07-10
- Accepted by EDGAR
- 2026-07-10 16:01 ET
- Event date
- 2026-07-06
- Accession no.
- 0001140361-26-028208
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements. - Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT FILING | crnx-20260706.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.